Experimental Study on Pharmacodynamics of Fuyankang Enema

FENG Feng1; HE Bai-yin1; LI Yuan-bin1; XIE You-liang1; JIANG Dong-xu1; LAI Xiao-ping1

doi:10.13422/j.cnki.syfjx.2012.16.047

您当前的位置：

首页 >

文章列表页 >

Experimental Study on Pharmacodynamics of Fuyankang Enema

更新时间：2024-09-23

- Experimental Study on Pharmacodynamics of Fuyankang Enema
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 16, Pages: 232-235(2012)
- 作者机构：
  
  1. 广州中医药大学新药研究开发中心
  2. 东莞广州中医药大学中医药数理工程研究院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2012.16.047
  CLC： R285.5
- Published：2012
- 稿件说明：
移动端阅览
[1]冯峰,何百寅,李远彬,谢友良,蒋东旭,赖小平.妇炎康药液灌肠法药效学研究[J].中国实验方剂学杂志,2012,18(16):232-235.

FENG Feng1, HE Bai-yin1, LI Yuan-bin1, et al. Experimental Study on Pharmacodynamics of Fuyankang Enema[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(16): 232-235.
[1]冯峰,何百寅,李远彬,谢友良,蒋东旭,赖小平.妇炎康药液灌肠法药效学研究[J].中国实验方剂学杂志,2012,18(16):232-235. DOI： 10.13422/j.cnki.syfjx.2012.16.047.

FENG Feng1, HE Bai-yin1, LI Yuan-bin1, et al. Experimental Study on Pharmacodynamics of Fuyankang Enema[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(16): 232-235. DOI： 10.13422/j.cnki.syfjx.2012.16.047.

摘要

目的:观察妇炎康灌肠剂对小鼠抗炎、镇痛和免疫系统的影响。方法:①选用240只SPF级昆明种小鼠随机分为模型组

西药组（吲哚美辛0.02520g.kg-1.d-1）

妇炎康ig高剂量组（220g.kg-1.d-1）

妇炎康灌肠高、中、低剂量组（2

0.520g.kg-1.d-1）。以小鼠腹腔伊文斯蓝溶液吸光度、二甲苯致耳肿胀度和抑制率、热刺激痛阈和醋酸所致小鼠扭体次数和初次扭体时间为指标

观察妇炎康灌肠各组给药420d对正常小鼠炎症抑制和痛阈的影响;②选用120只SPF级昆明种级小鼠

模型组代替西药组

余同①

以免疫抑制（0.02520g.kg-1.d-1醋酸泼尼松

ig201020d）小鼠脾脏指数、胸腺指数以及廓清指数为指标

观察妇炎康灌肠各组给药1020d对免疫低下小鼠免疫系统的影响。结果:妇炎康灌肠剂各组能不同程度降低二甲苯所致小鼠耳廓肿胀度（P<0.05或P<0.01）

提高小鼠痛阈（P<0.05）

减少醋酸所致扭体次数（P<0.05或P<0.01）

延迟初次扭体时间（P<0.05）;抑制醋酸泼尼松造成的小鼠脏器系数减小（P<0.05或P<0.01）和巨噬细胞廓清指数减小（P<0.05）。结论:妇炎康灌肠给药有抗炎镇痛及免疫调节作用。

Abstract

Objective:To study the pharmacodynamics on Fuyankang enema in treatment of chronic pelvic inflammatory disease

concerning anti-inflammatory

analgesic and immune.Method: Two hundred and forty Special-pathogen free KM rats were randomly divided into six groups: normal control group

western medicine group（Indomethacin 0.025 g · kg-1 · d-1）

high-dose Fuyankang ig group（2 g · kg-1 · d-1）

low-dose

middle-dose

and high-dose Fuyankang enema groups（2

0.5 g · kg-1 · d-1 respectively）.Effects of Fuyankang enema on abdominal capillary permeability

ear edema

hot-plate tests and writhing were observed.Other 120 rats were divided in the same way

but western medicine group was replaced by model group.Immune organ relative weight and the charcoal clearance index were also observed in prednisone acetate induced immunodepressive rats.Result: Fuyankang enema had inhibitory effects on mice ear edema（P<0.05 or P<0.01） and reduction of immune organ relative weight（P<0.05 or P<0.01） and charcoal clearance index（P<0.05） caused by prednisone had a reduction in ratio of writhing of mice（P<0.05） and had a addition on pain threshold of mouse（P<0.05）.Conclusion: Fuyankang enema has pharmaceutical effects in agreement with clinical effect on chronic pelvic inflammation

combination with oral medication is better.

关键词

Keywords

references

Views

106

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Anti-inflammatory,Analgesic and Relieving Rectal Ulceration Effects of the Eliminating Hemorrhoids Tablet

Anti-inflammatory and Analgesic Effects of Ligustilide

Analgesic and Anti-inflammatory Effects and Acute Toxicity of Wuling Jianzhou Pellet

Related Author

FENG Feng

HE Bai-yin

LI Yuan-bin

XIE You-liang

JIANG Dong-xu

LAI Xiao-ping

WANG Qiu-ju1

LV Juan2

Related Institution

Cangzhou Medical College

Chengde Jingfukang Pharmaceutical Group Co.,Ltd

Institute of Chinese Materia Medica,Chengde Medical College

Chinese PLA General of 69220 Military Hospital,Kuche

Department of Pharmacology,Xijiang Institute of Materia Medica

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰